Waters Corporation generates $3.8B in annual revenue across 3 key segments: Waters Advanced Diagnostics ($349.0M), Waters Analytical And Materials Sciences ($686.0M), and Waters Biosciences ($232.0M). The company-wide operating margin is 16.01%. Based on the Q1 2026 filing.